ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Guideline 2018 Year: 2018
ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: Eur Respir J, 52 (6) 1800610; 10.1183/13993003.00610-2018 Year: 2018
ERS statement on harmonised standards for lung cancer registration and lung cancer services in Europe Source: International Congress 2018 – State of the art session: Thoracic oncology Year: 2018
Clinical management of lung cancer in France: a national survey Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001
Lung cancer survival in the UK: are the results from the national lung cancer audit (LUCADA) dependent on completeness of case reporting? Source: Annual Congress 2009 - Epidemiology and management of lung cancer Year: 2009
Is there equitable access to PET-CT for lung cancer patients across a large UK cancer network; a retrospective study of 4597 patients Source: International Congress 2015 – Quality management in lung cancer Year: 2015
Centralisation of thoracic surgery services to a regional centre – the impact on cancer waiting times Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006
The approach to the surgical management of cancer in four European countries (Belgium, Greece, Switzerland, United Kingdom) Source: Eur Respir J 2003; 22: Suppl. 45, 31s Year: 2003
A randomised trial of active symptom control (ASC) with or without chemotherapy (CT) in the treatment of patients with malignant pleural mesothelioma. First results of the Medical Research Council/British Thoracic Society MS01 trial Source: Annual Congress 2007 - Pleural malignancy Year: 2007
ERS Taskforce harmonised standards for lung cancer (LC) registration in Europe and the current Greek screenshot;Is it a long way to Tipperary? Source: International Congress 2019 – Early detection, follow-up and epidemiology of lung cancer Year: 2019
Quality of life after lung resection due to malignant neoplasm in Brazilian patients Source: Annual Congress 2005 - New insights into prognosis in thoracic surgical oncology Year: 2005
What might its impact really be in Europe? Source: Annual Congress 2005 - A sceptical look at lung cancer screening Year: 2005
An audit on the use of FDG-PET in the diagnosis and management of lung cancer in a district general hospital in the West Midlands, U.K. Source: Annual Congress 2010 - Quality management for lung cancer patients Year: 2010
The European initiative for quality management in lung cancer care Source: Eur Respir J 2014; 43: 1254-1277 Year: 2014
The European initiative for quality management in lung cancer care Source: International Congress 2014 – The ERJ and ERR at the forefront of respiratory medicine: 2014 guidelines Year: 2014
The European initiative for quality management in lung cancer care Source: Guideline 2014 Year: 2014
COVID-19 and the management of thoracic cancer patients: challenges and recommendations Source: ERS webinar 2020: COVID-19 and the management of thoracic cancer patients: challenges and recommendations Year: 2020
Health inequalities in Europe: the situation for lung cancer Source: Annual Congress 2012 - Update on Tallinn summit: health inequalities in Europe Year: 2012
Chemotherapy for lung cancer in Scotland: a national survey Source: Eur Respir J 2002; 20: Suppl. 38, 465s Year: 2002
The feasibility of a lung cancer screening program in rural Ireland Source: Eur Respir J 2006; 28: Suppl. 50, 80s Year: 2006